Beacon Therapeutics has raised $170m in a Series B funding round to accelerate the development of its lead asset AGTC-501, for X-linked retinitis pigmentosa (XLRP). The financing round was led by ...

Bangladesh’s pharmaceutical industry has undergone ... access to life-saving drugs,” says Monjurul Alam, CEO of Beacon Medicare Ltd, adding that it was his vision that led to Beacon now ...

Beacon MedTech Solutions recently announced that Phil Littlefield will serve as director of operations, effective immediately. With a track record of success in global manufacturing, ...